2005•PubMedRequires access

[The adherence in the treatment of chronic hepatitis C].

Małgorzata Pawłowska, Waldemar Halota

Abstract

The most effective therapy for patients with chronic hepatitis C is combined therapy with pegylated interferon plus ribavirin. Adherence has been shown to enhance the sustained viral response (SVR) in patients receiving standard or pegylated interferon plus ribavirin. Treatment - related side effects affects on treatment quality of life and impact upon the ability of a patient to adhere to treatment. It is essential that they are managed quickly and effectively. In the work authors presented side effect of the therapy of chronic hepatitis C and management of this side effects providing to reduction them.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Ribavirin, Medicine, Pegylated interferon, Chronic hepatitis, Hepatitis C, Interferon, Side effect (computer science), Internal medicine